Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism. In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition. The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus. Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1alpha (PGC-1alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT is a negative regulator of PGC-1α (Figure 3B).”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
In the citing paper
“AKT phosphorylates and inhibits PGC-1α in response to insulin in liver [68] and activation of AKT causes a reduction in PGC-1α levels in heart [69].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [68]
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
Self-citation
Cited by
Items 201–300 of 497
Dröge, W., & Kinscherf, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1953 · Cited by 57
“In addition, Akt2 phosphorylates and inhibits the transcriptional coactivator PGC-1 (cid:4) , which is a global regulator of the postab-sorptive hepatic metabolism and works in close association with FOXO 1 (113, 152).”
Gluconeogenesis Flux in Metabolic Disease
Shah, A. M., & Wondisford, F. E. (2023) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-061121-091507 · Cited by 62
PIK3R3 regulates PPARα expression to stimulate fatty acid β-oxidation and decrease hepatosteatosis
Yang, X., Fu, Y., Hu, F., Luo, X., Hu, J., & Wang, G. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.243 · Cited by 61
Suh, H. N., Huong, H. T., Song, C. H., Lee, J., & Han, H. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00368.2008 · Cited by 64
“The intermediary protein kinase Akt2/protein kinase B (PKB)- , PGC-1 (24), p38 MAPK (9), and AMP-activated protein kinase (AMPK) (10) all promote gluconeogenesis in the liver.”
BackgroundSamjoo, I. A., Safdar, A., Hamadeh, M. J., Glover, A. W., Mocellin, N. J., Santana, J., Little, J. P., Steinberg, G. R., Raha, S., & Tarnopolsky, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066322 · Cited by 48
Wang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 58
Song, Y., Högstrand, C., Ling, S.-C., Chen, G.-H., & Luo, Z. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108364 · Cited by 57
“It also acts as a global regulator 77 of metabolism and regulates the expression of LD-related proteins in hepatocytes [10, 11].”
BackgroundProlonged exposure to insulin suppresses mitochondrial production in primary hepatocytes.
Liu, H.-Y., Yehuda-Shnaidman, E., Hong, T., Han, J., Pi, J., Liu, Z., & Cao, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807992200 · Cited by 54
Nada, S. E., Thompson, R. C., & Padmanabhan, V. (2010) · Endocrinology · doi:10.1210/en.2010-0666 · Cited by 54
Mitochondria mediated cell death in diabetes
Szabadkai, G., & Duchen, M. R. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0363-5 · Cited by 63
“In the liver, PGC-1a is phosphorylated by insulin/Akt signals [118] hampering its stimulatory effect on b-oxidation, thus, due to its extramitochondrial effects such as promoting gluconeogenesis, its overexpression reduces insulin sensitivity, an effect shared with its homologue, PGC-1b [119] .”
BackgroundBallester, M., Ramayo‐Caldas, Y., Revilla, M., Corominas, J., Castelló, A., Estellé, J., Fernández, A. I., & Folch, J. M. (2017) · Scientific Reports · doi:10.1038/srep46539 · Cited by 75
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 61
RNF34 Is a Cold-Regulated E3 Ubiquitin Ligase for PGC-1 α and Modulates Brown Fat Cell Metabolism
Wei, P. Y., Pan, D., Mao, C., & Wang, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05674-11 · Cited by 56
“naling (12, 22, 28, 33) and suggests that additional mechanisms”
BackgroundBoth gain and loss of Nampt function promote pressure overload-induced heart failure
Byun, J., Oka, S., Imai, N., Huang, C.-Y., Ralda, G., Zhai, P., Ikeda, Y., Ikeda, S., & Sadoshima, J. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00222.2019 · Cited by 54
Bucher, M., Montaniel, K. R. C., Myatt, L., Weintraub, S. T., Tavori, H., & Maloyan, A. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420001026 · Cited by 58
Ablation of PI3K p110-α Prevents High-Fat Diet–Induced Liver Steatosis
Chattopadhyay, M., Selinger, E. S., Ballou, L. M., & Lin, R. Z. (2011) · Diabetes · doi:10.2337/db10-0869 · Cited by 56
Cao, L., Li, Y. S., Smirnov, A., Voshtani, R., Wang, T., Shao, C., Candi, E., Melino, G., Shi, Y., & Fang, J. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01519-2 · Cited by 58
Dai, W., Panserat, S., Plagnes‐Juan, E., Seiliez, I., & Cassy, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430281 · Cited by 56
Low Levels of Physical Activity Increase Metabolic Responsiveness to Cold in a Rat (Rattus fuscipes)
Seebacher, F., & Glanville, E. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013022 · Cited by 50
Xie, X., Li, W., Lan, T., Liu, W., Peng, J., Huang, K., Huang, J., Shen, X., Liu, P., & Huang, H. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-024 · Cited by 51
Gehrke, N., Biedenbach, J., Huber, Y., Straub, B. K., Galle, P. R., Simon, P., & Schattenberg, J. M. (2019) · Scientific Reports · doi:10.1038/s41598-018-38321-9 · Cited by 43
Liver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 54
Regulation of basal expression of hepatic PEPCK and G6Pase by AKT2
He, L., Li, Y., Zeng, N., & Stiles, B. L. (2020) · Biochemical Journal · doi:10.1042/bcj20190570 · Cited by 52
Rozance, P. J., Limesand, S. W., Barry, J. S., Brown, L. D., Wesolowski, S. R., LoTurco, D., Regnault, T. R. H., Friedman, J. E., & Hay, W. W. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2007 · Cited by 53
“In addition, insulin has recently been shown to stimulate phosphorylation of PGC1 directly to inhibit its ability to activate PEPCK gene transcription (33).”
BackgroundPettersson-Klein, A. T., Izadi, M., Ferreira, D. M. S., Červenka, I., Correia, J. C., Martínez-Redondo, V., Southern, M. R., Cameron, M. D., Kamenecka, T. M., Agudelo, L. Z., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.017 · Cited by 54
Sun, X., Cao, Z., Ma, Y., Shao, Y., Zhang, J., Yuan, G., & Guo, X. (2020) · Food & Function · doi:10.1039/d0fo02387f · Cited by 54
Insulin Regulation of Hepatic Lipid Homeostasis
Uehara, K., Santoleri, D., Whitlock, A. E. G., & Titchenell, P. M. (2023) · Comprehensive Physiology · doi:10.1002/cphy.c220015 · Cited by 49
Verma, K., Jaiswal, R., Paliwal, S., Dwivedi, J., & Sharma, S. K. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30433 · Cited by 60
“PGC‐1a Ser(570) Inactivate Impair ability to promote gluconeogenesis and fatty acid oxidation [47]”
BackgroundPGC1s and Beyond: Disentangling the Complex Regulation of Mitochondrial and Cellular Metabolism
Coppi, L., Ligorio, S., Mitro, N., Caruso, D., Fabiani, E. D., & Crestani, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136913 · Cited by 50
“In the liver, this PTM is crucial to regulate glucose homeostasis; in particular, Akt-dependent phosphorylation results in inhibition of PGC1α by displacing it from chromatin and preventing transcriptional coactivation [46].”
BackgroundSirt1 is involved in energy metabolism: The role of chronic ethanol feeding and resveratrol
Oliva, J., French, B. A., Li, J., Bardag‐Gorce, F., Fu, P. C., & French, S. W. (2008) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.08.002 · Cited by 54
“In the cell survival pathway, FOXO3, KU-70 and GADD45 are up regulated and p53 and NFκB are down regulated (Engel and Mahlknecht, 2008; Hasegawa et al., 2008; Kobayashi et al., 2005; Li et al., 2007b; Luo et al., 2001; Vaziri et al., 2001; Yeung et al., 2004).”
Backgroundde Lange, P., Senese, R., Cioffi, F., Moreno, M., Lombardi, A., Silvestri, E., Goglia, F., & Lanni, A. (2008) · Endocrinology · doi:10.1210/en.2008-0202 · Cited by 50
Holloway, G. P., Perry, C. G. R., Thrush, A. B., Heigenhauser, G. J. F., Dyck, D. J., Bonen, A., & Spriet, L. L. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00726.2007 · Cited by 48
“These observations underscore the complexity of mechanisms that regulate protein expression, including the influence of phosphorylation on increasing PGC-1 mRNA stability (37) or activation (16, 25), the ability of other proteins to suppress PGC-1 activity (11), and the importance of nuclear import (48).”
BackgroundFasting-Induced Hepatic Production of DHEA Is Regulated by PGC-1α, ERRα, and HNF4α
Grasfeder, L. L., Gaillard, S. L., Hammes, S. R., Ilkayeva, O., Newgard, C. B., Hochberg, R. B., Dwyer, M. A., Chang, C., & McDonnell, D. P. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0024 · Cited by 52
Buchner, D. A., Yazbek, S. N., Solinas, P., Burrage, L. C., Morgan, M. G., Hoppel, C. L., & Nadeau, J. H. (2011) · Obesity · doi:10.1038/oby.2010.214 · Cited by 45
“Pgc-1α is a key mediator of hepatic metabolism (16) and was overexpressed in the liver of the obese strain 6C1 following 100 days on the HFSC diet.”
BackgroundUSP7 Attenuates Hepatic Gluconeogenesis Through Modulation of FoxO1 Gene Promoter Occupancy
Hall, J. A., Tabata, M., Rodgers, J. T., & Puigserver, P. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1420 · Cited by 45
Duan, L., Calhoun, S., Shim, D., Perez, R. E., Blatter, L. A., & Maki, C. G. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab018 · Cited by 45
“AKT can also downregulate and inhibit expression of PGC-1b (Southgate et al., 2005; Li et al., 2007).”
BackgroundZhu, Y., Hu, H., Zuo, M., Mao, L., Song, G., Li, T., Dong, L., Yang, Z., & Sheikh, M. S. A. (2021) · Biomedical Reports · doi:10.3892/br.2021.1432 · Cited by 46
“Moreover, it was reported that the expression of CREB and FoxO1 may be regulated by the AKT signaling pathway and the expression of PEPCK and G6Pase may be associated with AKT phosphorylation deficiency (32,33).”
BackgroundRomanino, K., Mazelin, L., Albert, V., Conjard-Duplany, A., Lin, S., Bentzinger, C. F., Handschin, C., Puigserver, P., Zorzato, F., Schaeffer, L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111448109 · Cited by 43
“Another reason for the lower activity of PGC-1α in mTORC1-deficient muscle could be the hyperactivation of PKB/Akt, which was shown to inhibit PGC-1α directly by phosphorylation in liver (20).”
BackgroundA proteomic atlas of insulin signalling reveals tissue‐specific mechanisms of longevity assurance
Tain, L. S., Sehlke, R., Jain, C., Chokkalingam, M., Nagaraj, N., Essers, P., Rassner, M., Grönke, S., Froelich, J., Dieterich, C., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177663 · Cited by 46
“However, as with many TFs and cofactors, the activity of Spargel and delg could be regulated on the posttranslational level (Li et al, 2007).”
BackgroundSong, L., Liu, J., Shi, T., Zhang, Y., Zhong, X., Cao, X., & Yang, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001639r · Cited by 46
Johnstone, C. N., Mongroo, P. S., Rich, A. S., Schupp, M., Bowser, M., deLemos, A. S., Tobias, J. W., Liu, Y., Hannigan, G. E., & Rustgi, A. K. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01617-06 · Cited by 52
“Parvin- , Parvin- , KLF4, and PGC-1 are described elsewhere (35, 43, 71).”
MethodSae‐tan, S., Rogers, C. J., & Lambert, J. D. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.01.036 · Cited by 43
The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD
Ghosh, S., Sharma, R., Bammidi, S., Koontz, V., Nemani, M., Yazdankhah, M., Kedziora, K. M., Stolz, D. B., Wallace, C. T., Yu-Wei, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50500-z · Cited by 44
“Intriguingly, we fi nd that increased AKT2 signaling inhibits PGC-1 α , a major transcription factor for mitochondrial biogenesis 32 – 34 that downregulates mitochondrial biogenesis genes including SIRT5 33 .”
Guo, G., Qiu, X., Wang, S., Chen, Y., Rothman, P. B., Wang, Z., Chen, Y., Wang, G., & Chen, J.-L. (2010) · Oncogene · doi:10.1038/onc.2010.149 · Cited by 42
“AKT1, AKT2 and AKT3 isoforms identified in mice and human constitute a distinct family of serine/threonine kinases, which has been implicated in diverse cellular processes, including proliferation, cell survival, metabolism and tumor cell invasion (Vivanco and Sawyers, 2002; Li et al., 2007).”
Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis
Gravel, S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00075 · Cited by 44
Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions
Liu, T., Wang, Y., Wang, Y., & Chan, A. M.-L. (2019) · Cancers · doi:10.3390/cancers11091247 · Cited by 43
“PTEN loss induced PI3K-AKT activation also inhibits forkhead box protein O1 (FOXO1) and proliferator-activated receptor-γ (PPARγ), thus affecting hepatic gluconeogenesis [111,112].”
BackgroundTargeting Mitochondrial Network Architecture in Down Syndrome and Aging
Mollo, N., Cicatiello, R., Aurilia, M., Scognamiglio, R., Genesio, R., Charalambous, M., Paladino, S., Conti, A. M. F., Nitsch, L., & Izzo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093134 · Cited by 41
“AKT, a key component of the insulin signaling pathway, inhibits PGC-1α by phosphorylating serine-570 [79].”
BackgroundKim, D., Kim, Y., Hynx, D., Wang, Y., Yang, K.-J., Ryu, D., Kim, K. S., Yoo, E.-K., Kim, J., Koo, S., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3366-x · Cited by 41
“However, additional transcriptional regulators, including cAMP response element-binding protein (CREB)regulated transcription coactivator 2, peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) and FOXO6, have also been reported to mediate insulin inhibition of gluconeogenesis in liver; and abnormal r…”
BackgroundSajan, M. P., Lee, M. C., Foufelle, F., Sajan, J., Cleland, C., & Farese, R. V. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.12.005 · Cited by 43
Tan, S., Li, S., Min, Y., Gisterå, A., Moruzzi, N., Zhang, J., Sun, Y., Andersson, J., Malmström, R. E., Wang, M., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15005 · Cited by 43
Cancer—A Major Cardiac Comorbidity With Implications on Cardiovascular Metabolism
Finke, D., Heckmann, M. B., Frey, N., & Lehmann, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.729713 · Cited by 42
“Muscle-specific proteins, such as myosin heavy chain, are thereby degraded (Li et al., 1998; Li and Reid, 2000).”
BackgroundPapa, S., Scacco, S., Rasmo, D. D., Signorile, A., Papa, F., Panelli, D., Nicastro, A., Scaringi, R., Santeramo, A., Roca, E., et al. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.03.013 · Cited by 45
KLF10 transcription factor regulates hepatic glucose metabolism in mice
Yang, X., Chen, Q., Sun, L., Zhang, H., Yao, L., Cui, X., Gao, Y., Fang, F., & Chang, Y. (2017) · Diabetologia · doi:10.1007/s00125-017-4412-2 · Cited by 39
VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis
Ni, H., Guo, M., Zhang, X., Jiang, L., Tan, S., Yuan, J., Cui, H., Min, Y., Zhang, J., Schlisio, S., et al. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0151 · Cited by 41
Staudinger, J. L., & Lichti-Kaiser, K. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700098c · Cited by 41
Zhao, Y., Tan, Y., Dai, J., Wang, B., Li, B., Guo, L., Cui, J., Wang, G., Li, W., & Cai, L. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.05.011 · Cited by 40
“This discrepancy of the profiles between PPAR-α and AMPK expressions suggests that changes of testicular PPAR-α expression and AMPK activationmay not directly be mediated by Akt-mediated signaling, rather than secondary to the impairment of glucose metabolism, while PGC-1α expression may be directly related to Akt cha…”
ResultRingseis, R., Mooren, F., Keller, J., Couturier, A., Wen, G., Hirche, F., Stangl, G. I., Eder, K., & Krüger, K. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100040 · Cited by 43
“In agreement with recent evidence that chronic HF feeding disrupts hepatic PPARa function [18, 19], we observed that, besides OCTN2, TMABA-DH, and BBD, the classical PPARa target gene ACO and the PPAR coactivators PGC-1a und PGC-1b, which cooperate with PPARa in the transcriptional control of PPARa target genes [26, 2…”
BackgroundPhosphorylation of Forkhead Protein FoxO1 at S253 Regulates Glucose Homeostasis in Mice
Zhang, K., Guo, X., Yan, H., Wu, Y., Pan, Q., Shen, Z., Li, X., Chen, Y., Li, L., Qi, Y., et al. (2019) · Endocrinology · doi:10.1210/en.2018-00853 · Cited by 39
Self-citationNicholas, L. M., Morrison, J. L., Rattanatray, L., Ozanne, S. E., Kleemann, D. O., Walker, S. K., MacLaughlin, S. M., Zhang, S., Martin‐Gronert, M. S., & McMillen, I. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084594 · Cited by 40
“It is not clear, however, whether exposure to maternal obesity results in insulin resistance in her offspring as a consequence of the impact of increased adiposity in insulin sensitive tissues [30,31] or as a consequence of the programming of changes in the abundance of insulin signalling molecules in these tissues [2…”
BackgroundZhang, P., Wang, W., Mao, M., Gao, R., Shi, W., Li, D., Calderone, R., Sui, B., Tian, X., & Meng, X. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.710285 · Cited by 46
Akanchise, T., & Angelova, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051562 · Cited by 39
“However, research has revealed that the ability of PGC-1 to promote gluconeogenesis and fatty acid oxidation is inhibited by protein kinase Akt2/protein kinase B (PKB), which acts as an intermediary trigger of phosphorylation and inhibition [62].”
BackgroundTff3, as a Novel Peptide, Regulates Hepatic Glucose Metabolism
Xue, Y., Shen, L., Cui, Y., Zhang, H., Chen, Q., Cui, A., Fang, F., & Chang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075240 · Cited by 37
Genetic models of PGC-1 and glucose metabolism and homeostasis
Rowe, G. C., & Arany, Z. P. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9273-5 · Cited by 43
“phosphorylation by Akt [59]; and S6K [60], acetylation/”
BackgroundActivating AKT2 Mutation: Hypoinsulinemic Hypoketotic Hypoglycemia
Arya, V. B., Flanagan, S. E., Schober, E., Rami-Merhar, B. M., Ellard, S., & Hussain, K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3228 · Cited by 38
Tabata, M., Rodgers, J. T., Hall, J. A., Lee, Y., Jedrychowski, M. P., Gygi, S. P., & Puigserver, P. (2014) · Diabetes · doi:10.2337/db13-1304 · Cited by 41
Kumar, A., Vashist, A., Kumar, P., Kalonia, H., & Mishra, J. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70930-1 · Cited by 38
“Reports suggest that fluvastatin enhanced transcriptional activating function within peroxisome proliferatoractivated receptor g coactivator-1a (PGC-1a), which serves as an inducible coactivator for a number of transcription factors to control energy metabolism [38, 49, 60].”
BackgroundLi, S., Wang, X., Zhang, J., Li, J., Liu, X., Ma, Y., Han, C., Zhang, L., & Zheng, L. (2018) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20187299 · Cited by 36
“Li and coworkers (26) found that Akt could regulate the process of hepatic glucose and lipid metabolism by suppressing fatty acid oxidation gene expression.”
Backgroundvan Westering, T. L. E., Johansson, H. J., Hanson, B., Coenen-Stass, A. M. L., Lomonosova, Y. N., Tanihata, J., Motohashi, N., Yokota, T., Takeda, S., Lehtiö, J., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra120.002345 · Cited by 37
Liao, C., Li, M., Chen, X., Tang, C., Quan, J., Bode, A. M., Cao, Y., & Luo, X. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02835-6 · Cited by 42
Insulin signaling in development
Suzawa, M., & Bland, M. L. (2023) · Development · doi:10.1242/dev.201599 · Cited by 36
Guanylyl Cyclase C in Colorectal Cancer: Susceptibility Gene and Potential Therapeutic Target
Lin, J. E., Li, P., Pitari, G. M., Schulz, S., & Waldman, S. A. (2009) · Future Oncology · doi:10.2217/fon.09.14 · Cited by 36
Tan, S., Zhang, J., Sun, Y., Gisterå, A., Sheng, Z., Malmström, R. E., Hou, M., Peng, J., Ma, C., Liao, W., et al. (2021) · Platelets · doi:10.1080/09537104.2021.1936479 · Cited by 35
“Reduced Akt phosphorylation/activity has been shown to attenuate phosphorylation of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) [19], which is associated with an enhanced PGC1α activitiy [36].”
BackgroundAkt2: A Critical Regulator of Cardiomyocyte Survival and Metabolism
Muslin, A. J. (2011) · Pediatric Cardiology · doi:10.1007/s00246-010-9879-2 · Cited by 41
“Akt family members can phosphorylate the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1a (PGC-1a), resulting in the nuclear exclusion of PGC-1a, inhibiting its ability to be a transcriptional coactivator for transcription factors such as peroxisome proliferator-activated receptor…”
BackgroundRodríguez-Hernández, M. A., de la Cruz‐Ojeda, P., Gallego, P., Navarro‐Villarán, E., Staňková, P., Campo, J. A. D., Kučera, O., Elkalaf, M., Maseko, T. E., Červinková, Z., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113902 · Cited by 35
Mitochondria and diabetes mellitus: untangling a conflictive relationship?
Schiff, M., Loublier, S., Coulibaly, A., Bénit, P., Ogier de Baulny, H., & Rustin, P. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1263-0 · Cited by 34
“Peroxisome proliferator-activated receptor g co-activator 1a (PGC- 1a) is the main stimulant of hepatic gluconeogenesis (Herzig et al. 2001; Saltiel and Kahn 2001; Yoon et al. 2001) and is inhibited by insulin ( Li et al. 2007; Puigserver et al. 2003; Yoon et al. 2001).”
BackgroundSun, X., Ping, Y., Li, X., Mao, Y., Chen, Y., Shi, L., Hong, X., Chen, L., Chen, S., Cao, Z., et al. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13811 · Cited by 31
Self-citationRohrbach, S., Aslam, M., Niemann, B., & Schulz, R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12650 · Cited by 38
“However, Akt2 also phosphorylates PGC-1α at Ser570 preventing its recruitment to the promoter of PGC-1α target genes (Li et al., 2007b), possibly reducing mitochondrial biogenesis.”
BackgroundOkamoto, T., Kanemoto, N., Ban, T., Sudo, T., Nagano, K., & Niki, I. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.015 · Cited by 31
Parvaiz, F., Manzoor, S., Iqbal, J., Sarkar-Dutta, M., Imran, M., & Waris, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12361 · Cited by 33
Bruns, I., Sauer, B., Burger, M. C., Eriksson, J. A., Hofmann, U., Braun, Y., Harter, P. N., Luger, A., Ronellenfitsch, M. W., Steinbach, J. P., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006993 · Cited by 35
Linking Metabolic Disease With the PGC-1α Gly482Ser Polymorphism
Vandenbeek, R., Khan, N. P., & Estall, J. L. (2017) · Endocrinology · doi:10.1210/en.2017-00872 · Cited by 40
The PGC-1/ERR network and its role in precision oncology
Vitto, H. D., Bode, A. M., & Dong, Z. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0081-6 · Cited by 33
Qin, S.-G., Tian, H., Wei, J. J., Han, Z.-H., Zhang, M., Hao, G., Liu, X., & Pan, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00722 · Cited by 32
“A previous study in hepatocytes found that Akt directly phosphorylated PGC1α and inhibited the recruitment of PGC1α to its cognate promoter regions (Li et al., 2007).”
BackgroundZheng, B., Zhao, X., Ao, T., Chen, Y., Xie, J., Gao, X., Liu, L., Hu, X., & Yu, Q. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.140345 · Cited by 30
Li, X., Zhuge, Z., Carvalho, L. R. R. A., Braga, V. A., Lucena, R. B., Li, S., Schiffer, T. A., Han, H., Weitzberg, E., Lundberg, J. O., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102266 · Cited by 29
“The inhibitory phosphorylation of PGC1α, is associated with decreased PGC1α activity and therefore decreased fatty acid oxidation [16,17].”
BackgroundSelf-citationTargeting Mitochondrial Sirtuins in Age-Related Neurodegenerative Diseases and Fibrosis
Xiao, H., Xie, Y., Xi, K., Xie, J., Liu, M., Zhang, Y., Cheng, Z., Wang, W., Guo, B., & Wu, S. (2023) · Aging and Disease · doi:10.14336/ad.2023.0203 · Cited by 32
Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice
Sinderen, M. L. V., Steinberg, G. R., Jørgensen, S. B., Honeyman, J. E., Chow, J. D. Y., Herridge, K. A., Winship, A., Dimitriadis, E., Jones, M. E. E., Simpson, E. R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136143 · Cited by 33
PGC-1α Regulates Translocated in Liposarcoma Activity: Role in Oxidative Stress Gene Expression
Sánchez‐Ramos, C., Tiérrez, A., Fabregat‐Andrés, Ó., Wild, B., Sánchez‐Cabo, F., Arduini, A., Dopazo, A., & Monsalve, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3643 · Cited by 34
Barjaste, A., Mirzaei, B., Rahmani-nia, F., Haghniyaz, R., & Brocherie, F. (2020) · Science & Sports · doi:10.1016/j.scispo.2020.03.006 · Cited by 31
Regulation of PPARγCoactivator-1αFunction and Expression in Muscle: Effect of Exercise
Uguccioni, G., D'souza, D., & Hood, D. A. (2010) · PPAR Research · doi:10.1155/2010/937123 · Cited by 28
“In contrast, phosphorylation by Akt on Ser570 results in an unstable protein with impaired activity [41].”
BackgroundMitochondria in response to nutrients and nutrient-sensitive pathways
Baltzer, C., Tiefenböck, S. K., & Frei, C. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.07.009 · Cited by 34
“PGC-1α is directly phosphorylated by Akt2, a key protein kinase of the insulin signalling pathway, leading to reduced expression of genes involved in gluconeogenesis and β-oxidation (Li et al., 2007).”
BackgroundKlotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis
Li, Q., Li, Y., Liang, L., Li, J., Luo, D., Liu, Q., Cai, S., & Li, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0241-2 · Cited by 28
Self-citationWesolowski, S. R., Sekar, S. M., Lavezzi, J. R., O'Meara, M. C., Brown, L. D., Hay, W. W., & Rozance, P. J. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00331.2012 · Cited by 30
“ERRA expression was further increased in the HG INS group, however, which could be due to insulindependent effects on stimulating hepatic oxidative metabolism or insulin’s effects on regulating PGC-1 function separate from its effects on PGC1A expression (15, 21, 30, 41).”
BackgroundThe hepatic FOXQ1 transcription factor regulates glucose metabolism in mice
Cui, Y., Qiao, A., Jiao, T., Zhang, H., Xue, Y., Zou, Y., Cui, A., Fang, F., & Chang, Y. (2016) · Diabetologia · doi:10.1007/s00125-016-4043-z · Cited by 31
Li, W., Cao, J., Wang, X., Zhang, Y., Sun, Q., Jiang, Y., Yao, J., Li, C., Wang, Y., & Wang, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.773834 · Cited by 43
“So far, accumulating studies reported that PGC-1α is significantly regulated posttranslationally by phosphorylation, acetylation, and methylation (Puigserver et al., 2001; Rodgers et al., 2005; Li et al., 2007), among which deacetylation and reactivation of PGC-1α mediated by NAD+dependent SIRT1 deacetylase have gradu…”
BackgroundActivated polyamine catabolism leads to low cholesterol levels by enhancing bile acid synthesis
Pirinen, E., Gylling, H., Itkonen, P., Yaluri, N., Heikkinen, S., Pietilä, M., Kuulasmaa, T., Tusa, M., Cerrada‐Gimenez, M., Pihlajamäki, J., et al. (2009) · Amino Acids · doi:10.1007/s00726-009-0416-7 · Cited by 30
“The induction of PGC-1a was best explained when western blots of an inhibitor of PGC-1a (Li et al. 2007), Akt, were analyzed.”
BackgroundAkt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity
Etzion, S., Etzion, Y., DeBosch, B. J., Crawford, P. A., & Muslin, A. J. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.011 · Cited by 29
Wang, W., & Wong, C. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0561-1 · Cited by 28
“Serine 571 of PGC-1α has been shown to be phosphorylated by Akt, which in turn impairs PGC-1α activity [ 10 ].”
BackgroundInfluentialYang, Y.-N., Zhang, M.-Q., Yu, F.-L., Han, B., Bao, M.-Y., Yan-He, Yan-he, & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115717 · Cited by 26
Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis
Lee, J.-M., Seo, W., Han, H.-S., Oh, K., Lee, Y. S., Kim, D., Choi, S., Choi, B. H., Harris, R. A., Lee, C., et al. (2015) · Diabetes · doi:10.2337/db15-0249 · Cited by 26
“A previous report showed that insulin and PKB inhibit FOXO1 and PGC-1a activity by a phosphorylation-dependent mechanism (5,20,27).”
Background
Metadata
- Authors
- Li, X., Monks, B., Ge, Q., & Birnbaum, M. J.
- Affiliations
- Howard Hughes Medical Institute (US)
- Cell Signaling Technology (United States) (US)
- Corresponding author
- Birnbaum, Morris J.
- Venue
- Nature
- Published
- 2007-06
- Volume
- 447
- Issue
- 7147
- Pages
- 1012-1016
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982810858
- Cited by
- 487
- References
- 29
- Citations by year
- 2026: 6 · 2025: 19 · 2024: 25 · 2023: 19 · 2022: 16 · 2021: 26 · 2020: 33 · 2019: 21 · 2018: 27 · 2017: 24 · 2016: 15 · 2015: 24 · 2014: 26 · 2013: 24 · 2012: 32
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1α, insulin signaling, hepatic metabolism, type 2 diabetes, insulin resistance, gluconeogenesis, fatty acid oxidation, cardiovascular disease
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Chromatin, Diabetes Mellitus, Type 2, Gene Expression Regulation, Glucose, Liver, Phosphorylation, Phosphoserine, Transcription Factors, Trans-Activators, Down-Regulation, Cell Line, Tumor, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.